Journal article
Risks for stroke, bleeding, and death in patients with atrial fibrillation receiving dabigatran or warfarin in relation to the CHADS2 score: a subgroup analysis of the RE-LY trial.
Abstract
BACKGROUND: CHADS(2) is a simple, validated risk score for predicting the risk for stroke in patients with atrial fibrillation not treated with anticoagulants. There are sparse data on the risk for thrombotic and bleeding complications according to the CHADS(2) score in patients receiving anticoagulant therapy.
OBJECTIVE: To evaluate the prognostic importance of CHADS(2) risk score in patients with atrial fibrillation receiving oral …
Authors
Oldgren J; Alings M; Darius H; Diener H-C; Eikelboom J; Ezekowitz MD; Kamensky G; Reilly PA; Yang S; Yusuf S
Journal
Annals of Internal Medicine, Vol. 155, No. 10, pp. 660–w204
Publisher
American College of Physicians
Publication Date
November 15, 2011
DOI
10.7326/0003-4819-155-10-201111150-00004
ISSN
1056-8751